Detalles de la búsqueda
1.
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
Nature
; 487(7408): 505-9, 2012 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-22763448
2.
Elevated Levels of BRAFV600 Mutant Circulating Tumor DNA and Circulating Hepatocyte Growth Factor Are Associated With Poor Prognosis in Patients With Metastatic Melanoma.
JCO Precis Oncol
; 2: 1-17, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135117
3.
Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations.
ACS Chem Biol
; 11(10): 2897-2907, 2016 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27571029
4.
HGF as a circulating biomarker of onartuzumab treatment in patients with advanced solid tumors.
Mol Cancer Ther
; 12(6): 1122-30, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23536720
5.
Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity.
J Immunother
; 30(6): 644-54, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17667528
Resultados
1 -
5
de 5
1
Próxima >
>>